| Document |
Document Title |
|
WO/2022/160357A1 |
Disclosed are a monomer for a polymer gel, a polymer gel and a preparation method therefor. The preparation method comprises: reacting 4,4',4''-trihydroxytriphenylmethane with tert-butyldimethylchlorosilane to obtain TPC-OTBS; reacting 4...
|
|
WO/2022/117575A1 |
The present invention refers to a route for the conversion of ethane to ethylene glycol which involves reacting ethane with concentrated sulfuric acid in the presence of an iodine compound. In particular, the present invention includes a...
|
|
WO/2022/084046A1 |
The present invention relates to a process for preparing methyl methacrylate (MMA) and/or methacrylic acid (MAS) with improved yield, comprising the process steps of amidation, conversion and hydrolysis/esterification, especially high yi...
|
|
WO/2022/055203A1 |
Provided are a fatty acid glyceride compound containing sulfate and an amine group, a strain for producing same, a method for producing same, and uses of same. The fatty acid glyceride compound has antibacterial activity, particularly ag...
|
|
WO/2022/055782A1 |
There is disclosed a cyclic process for producing taurine from monoethanolamine comprising the steps of: (a) reacting monoethanolamine with ammonium sulfate in the recycling mother liquor to yield monoethanolamine sulfate; (b) reacting t...
|
|
WO/2022/006485A1 |
The present invention relates to fabric and home care products comprising sulfatized esteramines obtainable by a process comprising step a), wherein at least one alcohol containing at least two hydroxy groups (compound (A)) is reacted wi...
|
|
WO/2021/262439A2 |
A method of producing a reduced glycol fatty alcohol ethoxylate material may include removing at least a portion of glycol in the fatty alcohol ethoxylate material. A method of producing a reduced glycol sulfate ethoxylated sulfate surfa...
|
|
WO/2021/180080A1 |
Disclosed in the present invention are a compound and a preparation method therefor, wherein the compound has a structure as shown in formula (I) and formula (II). The compound is used in the prevention or treatment of myopia-related dis...
|
|
WO/2021/174209A1 |
Provided are sulfated pillarerenes and methods of making and using same. The pillararenes have macrocycle core having a plurality of aryl groups, attached (e.g., covalently bonded) in a para orientation to the adjacent methylene groups. ...
|
|
WO/2021/155474A1 |
Cannabinoid sulfate esters, their soluble salts and stable formulations thereof, as well as their edible, beverage and medicinal applications. The cannabinoid sulfate ester salts may be used as drugs or prodrugs for treating various cond...
|
|
WO/2021/106468A1 |
The purpose of the present invention is to provide a fluorine-containing anionic surfactant having excellent surface tension reduction ability and water solubility due to the use of a fluorine-containing compound composed of a perfluoroa...
|
|
WO/2021/049492A1 |
[Problem] A purpose of the present invention is to provide: a higher secondary alcohol alkoxylate adduct that when used as a surfactant, exhibits excellent cleaning power, and does not have unpleasant odor and is free from turbidity and ...
|
|
WO/2021/041481A1 |
Provided herein is a green laundry detergent composition that is pH neutral and comprises a powerful cleansing surfactant, an organic and sustainable broad-spectrum antimicrobial agent, a high purity natural, renewable and biodegradable ...
|
|
WO/2021/026257A1 |
Described herein are compounds and pharmaceutical compositions containing such compounds which are prodrugs of ALOX-15 inhibitors. Also described herein are methods for using such compounds in the treatment of disease.
|
|
WO/2020/218365A1 |
[Problem] To provide a curable composition which has excellent curability, preferably can contain water that is environment-friendly, can be cured into a cured film having excellent adhesiveness to a base material, particularly to a plas...
|
|
WO/2020/185420A1 |
Provided herein are integrated methods and systems for the production of acrylamide and acrylonitrile compounds and other compounds from at least beta-lactones and/or beta-hydroxy amides.
|
|
WO/2020/144030A1 |
The present invention relates to a process for the synthesis of organosulfate salts of amino acid esters comprising the steps of reacting at least one lactam with at least 3 carbon atoms in the lactam ring with sulfuric acidin an aqueous...
|
|
WO/2020/028322A1 |
Improvements in catalyst systems and associated processes for the conversion of glycolaldehyde to monoethanolamine are disclosed. The catalyst systems exhibit improved selectivity to this desired product and consequently reduced selectiv...
|
|
WO/2019/181587A1 |
The present invention addresses the problem of providing: a near-infrared-absorbing composition which has excellent near-infrared absorbing ability and in which dispersibility of a metal complex, particularly a copper complex, and disper...
|
|
WO/2019/121946A1 |
The present invention relates to a zwitterionic pillararene derivative having a structure according to the following general formula (I). Thereby, residue R is a zwitterionic hydrocarbon chain. The invention further relates to uses of su...
|
|
WO/2019/101132A1 |
Disclosed in the present invention are a fluorosulfonyl-containing compound, an intermediate thereof, a preparation method therefor and use thereof. The fluorosulfonyl-containing compound disclosed in the present invention comprises a ca...
|
|
WO/2019/092368A1 |
The invention relates to the compounds of formula (I), in which R1 and R2 represent a linear, branched or cyclic, saturated or unsaturated hydrocarbon group, comprising 1 to 6 carbon atoms, wherein the sum of the carbon atoms of the grou...
|
|
WO/2019/053700A2 |
Probe embodiments for identifying analytes involved in biofuel or bioenergy production, bioremediation, or nutrient cycling as well as methods of making and use are described herein. In some embodiments, probes identifying cellulose degr...
|
|
WO/2019/047493A1 |
The present invention relates to an ionic liquid, a cation of which contains a hexafluoroisopropylsulfonic acid group. The ionic liquid provided by the present invention introduces a hexafluoroisopropylsulfonic acid group into a cationic...
|
|
WO/2019/008441A1 |
Provided are a compound including a cleavable linker, a use thereof, and an intermediate compound for preparing the same, and more particularly, the compound including a cleavable linker of the present invention may include an active age...
|
|
WO/2018/187560A1 |
A surfactant composition is disclosed comprising a first alkyl sulfate surfactant, optionally a second alkyl sulfate surfactant, and optionally an alkyl ether sulfate. The first and second alkyl sulfate surfactants have Formula (1): R1-O...
|
|
WO/2018/187463A1 |
The present invention is directed to surfactants with small hydrophobes, which are of non-conventional hydrophobe size. The surfactants of the present invention utilize a small hydrophobic moiety with a polyalkoxylate chain comprising PO...
|
|
WO/2018/181898A1 |
The purpose of the present invention is to provide a novel production method for a fluoropolymer. This production method for a fluoropolymer includes a step in which a fluoropolymer is obtained by polymerizing a fluoromonomer in an aqueo...
|
|
WO/2018/181906A1 |
Provided is a novel alkyl sulfate ester having a carbonyl group, or a salt of this alkyl sulfate ester. A compound which is characterized by being represented by formula R1-C(=O)-(CR2 2)n-(OR3)p-(CR4 2)q-L-OSO3X. (In the formula, R1 repr...
|
|
WO/2018/172783A1 |
There is described a method of reducing polymer tar build-up in the production of methyl methacrylate and/or methacrylic acid by the acetone cyanohydrin process. In the method a stabiliser is contacted with the amide stage reaction mediu...
|
|
WO/2018/165257A1 |
Disclosed are dendritic anionic lipids which are compounds of Formula (I) : wherein R and R1 are non-polar groups, L is a linking moiety, and Dm is a dendritic moiety of m generations, each as defined herein. These dendritic anionic lipi...
|
|
WO/2018/148465A1 |
Biodegradable surfactants are described, in which an amphiphilic heteroatom containing hydrocarbon optionally comprising at least one counterion (Z), and related compositions, methods and systems. Biodegradable surfactant described herei...
|
|
WO/2018/102418A1 |
The present invention relates to processes for preparing a compound of Formula (I), or a pharmaceutically acceptable salt or solvate thereof. These compounds and pharmaceutical compositions are useful as FXR or TGR5 modulators. Specifica...
|
|
WO/2018/096504A1 |
Compounds of Formula (I), including stereoisomers and salts thereof, and compositions, methods of treatment and prevention, and methods of preparing, the same: Formula (I) wherein X is O or a direct bond; wherein when X is O, R1 and R2 a...
|
|
WO/2018/062450A1 |
Provided are a novel hydrocarbon-containing carboxylic acid, hydrocarbon-containing sulfonic acid, hydrocarbon-containing sulfuric acid ester or salt thereof, and a surfactant. The present invention is a compound which is characterized b...
|
|
WO/2018/062448A1 |
Provided are: a novel sulfuric acid ester having a plurality of carbonyl groups, or a salt of this sulfuric acid ester; and a surfactant. A compound which is characterized by being represented by formula R1-C(=O)-R2-C(=O)-R3-OSO3X. (In t...
|
|
WO/2018/053738A1 |
The present invention relates to a compound of formula (I) : R1O— (CH2CH2O) x—(CH2CH (R2) -O) y—SO3M, wherein R1, R2, x, y and M are defined herein. The present invention also relates to a composition comprising the compound of for...
|
|
WO/2017/191932A1 |
Provided are a novel water-soluble diacetylene monomer, a photolithography composition comprising the water-soluble diacetylene monomer and a conductive polymer, and a fine pattern preparation method using same. The water-soluble diacety...
|
|
WO/2017/184598A1 |
The present application relates to a method of preparing a bile acid derivative, or a pharmaceutical acceptable salt, solvate, or amino acid conjugate thereof, comprising reactin Compound 2 with paraldehyde to form Compound 3: Formula
|
|
WO/2017/179026A1 |
Method and unit for reducing dioxane produced as a result of sulfonation of alcohol ether sulfates, said reduction being carried out by at least one distillation step in at least one flash evaporator tank under vacuum. It involves supply...
|
|
WO/2017/138068A1 |
The present invention relates to: a method for producing a compound represented by formula (1), which comprises a step for hydrolyzing a compound represented by formula (2) under acidic or basic conditions, a step for reacting a compound...
|
|
WO/2017/074220A1 |
The invention relates to methods for producing fluorinated acid esters, particularly bromodifluoroacetic acid and especially ethyl bromodifluoroacetate. Ethyl bromodifluoroacetate is an important reaction intermediate in the synthesis of...
|
|
WO/2017/069058A1 |
Provided is an electrolytic solution with which it is possible to obtain a module or an electrochemical device such as a lithium-ion secondary cell in which generation of gas is less likely to occur even when stored in a high temperature...
|
|
WO/2017/048528A1 |
Disclosed are a variety of amphoteric compounds containing a quaternary nitrogen group, a covalently bound counterion, and an ester or amide group. These amphoteric compounds can be advantageously prepared via a chemoenzymatic green proc...
|
|
WO/2017/021113A1 |
Surfactants of the general formula (I) in which R1 is a linear or branched akyl radical having 6 to 20, especially 10 to 16 C atoms, R2 and R3 independently of one another are H or H3CO, and M is hydrogen, an alkali metal or a moiety N+R...
|
|
WO/2016/029888A1 |
The present invention provides amphiphilic compounds with tetradecahydrophenanthrene skeleton and their enantiomers, exhibiting neuroprotective effects, their use as medicaments for treating neuropsychiatric disorders associated with an ...
|
|
WO/2015/142928A1 |
The invention relates to administration of various pharmaceutical formulations of N- (4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluor
ophenyl)cyclopropane-1,1- dicarboxamide, (cabozantinib) a c-Met inhibitor, and its metaboli...
|
|
WO/2015/077451A1 |
The present invention relates to N-phenyl carbamate derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide 2 receptor.
|
|
WO/2015/055844A1 |
The invention relates to an hydrolysis vessel (200) used during amidification step of acetone cyanohydrin (ACH), in the industrial process for production of a methyl methacrylate (MMA) or methacrylic acid (MAA). The hydrolysis vessel (20...
|
|
WO/2015/040967A1 |
Provided is a novel compound useful for adjusting sweetness or saltiness or for ENaC inhibition, and an application thereof. This octenyl sulfate ester or salt thereof is indicated by formula (1) (in the formula, the wavy line indicates ...
|
